Tier 3 reports for 'TOCILIZUMAB FOR INJECTION' and 'solution'
Tier 3 Drug Shortages
3 reports found
| Brand name | Company Name | Date Updated | Strength(s) | Status | Report ID |
|---|---|---|---|---|---|
| ACTEMRA | HOFFMANN-LA ROCHE LIMITED | 2022-06-23 | 80MG | Avoided shortage | 144365 |
| ACTEMRA | HOFFMANN-LA ROCHE LIMITED | 2022-06-23 | 400MG | Avoided shortage | 144440 |
| ACTEMRA | HOFFMANN-LA ROCHE LIMITED | 2022-06-23 | 200MG | Avoided shortage | 155146 |
Showing 1 to 3 of 3
Tier 3 Drug Discontinuations
0 reports found
| Brand name | Company Name | Date Updated | Strength(s) | Status | Report ID |
|---|
Showing 1 to 0 of 0